Literature DB >> 27080816

Blockade of the Renin-Angiotensin System and the Risk of Acute Kidney Injury.

Michel Burnier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27080816      PMCID： PMC8031904          DOI： 10.1111/jch.12821

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  12 in total

Review 1.  Efficacy and safety of angiotensin receptor blockers in older patients: a meta-analysis of randomized trials.

Authors:  Islam Y Elgendy; Tianyao Huo; Veronica Chik; Carl J Pepine; Anthony A Bavry
Journal:  Am J Hypertens       Date:  2014-11-11       Impact factor: 2.689

2.  'To block or not to block'; whether to continue renin-angiotensin-aldosterone system blockade in advanced chronic kidney disease.

Authors:  Marit D Solbu; Alan G Jardine
Journal:  Nephrol Dial Transplant       Date:  2015-10-06       Impact factor: 5.992

Review 3.  Converting enzyme inhibitors and renal function in essential and renovascular hypertension.

Authors:  A Mimran; J Ribstein; G DuCailar
Journal:  Am J Hypertens       Date:  1991-01       Impact factor: 2.689

4.  Comparison of captopril and enalapril in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; M Yushak; N Medina
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

5.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Authors:  B Pitt; R Segal; F A Martinez; G Meurers; A J Cowley; I Thomas; P C Deedwania; D E Ney; D B Snavely; P I Chang
Journal:  Lancet       Date:  1997-03-15       Impact factor: 79.321

6.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Authors:  Johannes F E Mann; Roland E Schmieder; Matthew McQueen; Leanne Dyal; Helmut Schumacher; Janice Pogue; Xingyu Wang; Aldo Maggioni; Andrzej Budaj; Suphachai Chaithiraphan; Kenneth Dickstein; Matyas Keltai; Kaj Metsärinne; Ali Oto; Alexander Parkhomenko; Leopoldo S Piegas; Tage L Svendsen; Koon K Teo; Salim Yusuf
Journal:  Lancet       Date:  2008-08-16       Impact factor: 79.321

7.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

Review 8.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 9.  Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.

Authors:  M Burnier; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

10.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245
View more
  1 in total

1.  Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice.

Authors:  Suzanne J Faber; Nynke D Scherpbier; Hans J G Peters; Annemarie A Uijen
Journal:  BMC Nephrol       Date:  2019-12-04       Impact factor: 2.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.